How We Helped a Class II Device Manufacturer Achieve 200% of First-Year Revenue Targets

Once a Class II medical device gets FDA 510(k) clearance, companies face immediate commercial pressure. The chance to make a strong market entry is brief, and stakeholders want to see fast revenue growth. We worked with a manufacturer in this position and helped them exceed their first-year revenue targets by 200% in just 12 months. Here’s how we did it.

What Was the Starting Situation Before the Launch?

The manufacturer created a Class II surgical device that earned 510(k) clearance after a thorough review. The product filled a clinical gap in orthopedic procedures. However, the company had limited commercial resources. They had strong R&D and regulatory teams, but only one marketing generalist without device experience. Their small sales team covered just three territories.

The company set a cautious first-year revenue goal based on conservative market estimates. Their early plan depended mostly on attending trade shows and having sales reps reach out directly to orthopedic surgeons. They did not have a website for lead generation, and their digital presence was just a basic corporate page. There was no content strategy to reach healthcare professionals during their own research.

Challenges we identified during our initial assessment:

• No digital buyer journey: Healthcare professionals looking for solutions to this clinical problem could not find anything about the device on the company’s website. Competitors showed up in every search result instead.
• Undefined buyer personas: The company grouped all decision-makers as “surgeons,” missing important differences between orthopedic surgeons (end-users), procurement committee members (evaluators and approvers), hospital administrators (who control budgets), and clinical champions (internal advocates). Each group has its own priorities and role in the buying process.
• Weak value proposition messaging: The product materials focused on technical details instead of showing how the device improves patient outcomes, saves money, or streamlines workflow—factors that matter to purchasing committees.
• No post-launch marketing plan: Other than a trade show schedule, there was no step-by-step commercial plan for the year after clearance.

“Most medical device companies pour years of effort into getting clearance, then scramble to commercialize with a fraction of that same planning. The launch is where strategy either multiplies your investment or lets it quietly erode.” – Strategy Team, Emulent Marketing.

How Did We Structure the Go-to-Market Strategy?

We divided the 12 months after launch into three clear phases. Each phase had specific goals, tactics, and ways to measure success. This approach gave the sales team direction and let us make changes based on real-time data.

Before we started, we reviewed what the top five competing device makers were doing online. Most still relied on in-person sales visits and had little digital content. Only one had invested in SEO and educational materials. This gap gave us a clear chance to reach healthcare professionals online before others did.

What Role Did Brand Positioning Play in Driving Revenue?

One of the first things we tackled was the company’s brand strategy. The device itself was clinically strong, but its messaging was generic. Every competitor claimed to be “precise” and “reliable.” These words had become background noise in the orthopedic device space.

We worked with the clinical team and early-adopting surgeons to clarify what sets this device apart. Interviews and outcome data highlighted two clear advantages: a 40% reduction in average procedure time compared with the top competitor and a measurable decrease in post-operative complications, as demonstrated by early clinical evidence. These advantages shape a value proposition focused on delivering better patient outcomes and reducing the total cost of care—key priorities for purchasing committees.

Next, we created brand messaging for each type of buyer. Surgeons got information about efficiency and clinical results. Hospital administrators and procurement teams received materials about health economics, shorter operating room time, and long-term cost savings. This targeted approach gave everyone involved in the decision a reason to support the product.

“You cannot win a medical device sale with a single message aimed at a single person. Purchasing committees include clinicians, financial officers, and administrators who each evaluate products through a completely different lens. Your marketing has to meet all of them where they are.” – Strategy Team, Emulent Marketing.

How Did Digital Marketing Drive Qualified Leads to the Sales Team?

Our digital marketing strategy focused on capturing existing demand. Surgeons and procurement professionals were already searching for solutions online, but this manufacturer was not showing up. We fixed this by using a coordinated approach across several channels.

Key digital marketing tactics and their measured results:

• Website redesign for lead generation: We rebuilt the company’s website to align with the buyer journey. We added dedicated pages for each persona, a clinical evidence library, and clear paths to request a demo or speak with a sales rep. Within 90 days, completions of the demo request form increased by 340%.
• Search engine visibility: We did keyword research and created an SEO strategy focused on the clinical problems the device solves, not just its name. We also built authority around the orthopedic condition and treatment methods.
• Educational content program: We developed a B2B content strategy that included surgical technique guides, outcome comparisons, and white papers on health economic benefits. This content brought in organic search traffic and gave sales reps useful materials for outreach.
• LinkedIn advertising: We used account-based targeting to reach orthopedic department heads and surgical directors at the top 200 hospital systems. These campaigns had a 4.2% click-through rate, much higher than the 0.44% industry average for healthcare LinkedIn ads.

The data tells a clear story. Trade shows delivered strong lead-to-demo conversion rates, but the cost per lead was nearly 8x higher than for organic search. Once content gained traction around month four, organic search became the highest-volume and most cost-efficient channel. This pattern recurs in pharmaceutical and life sciences marketing: digital channels compound over time, while event-based channels remain linear.

Why Did Content and Trust Signals Matter So Much for Conversions?

Buying a medical device is a big financial and clinical risk. When a hospital system chooses a new surgical device, it impacts patient outcomes, staff training, inventory, and budgets. Because of this, buyers do a lot of research before talking to a sales rep.

We added trust signals at every step of the buyer journey. We shared peer-reviewed clinical data summaries and created video testimonials from early adopter surgeons. The clinical team contributed articles to trade publications to build credibility. We also made sure the website showed strong E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) signals so search engines would see the content as reliable medical information.

Actions we took to build credibility across the buyer journey:

• Clinical evidence library: We organized and published all available outcome data, surgeon testimonials, and procedure documentation in a searchable resource center. Access to the center required registration, giving sales teams warm leads.
• Key Opinion Leader (KOL) partnerships: We worked with three respected orthopedic surgeons who shared case stories and joined webinars. Their involvement showed other surgeons that the device had strong clinical support.
• Regulatory transparency pages: We built pages that explained the 510(k) clearance process, the device’s classification, and post-market monitoring commitments. This openness helped procurement teams feel confident about compliance before making a decision.
• Structured data and entity SEO: We implemented structured data markup. We also expanded the company’s presence in medical databases and directories. As a result, search engines better understood and represented the brand in results.

“Trust does not come from claiming you are trustworthy. It comes from demonstrating transparency at every point where a buyer might hesitate. In medical devices, that means showing your clinical data, your regulatory standing, and your real-world outcomes before anyone asks.” – Strategy Team, Emulent Marketing.

How Did We Align Marketing With the Sales Cycle?

Medical device sales cycles take a long time. For a Class II surgical device, the average B2B sales cycle is 6 to 18 months from first contact to purchase order. We needed marketing to help sales at every stage, not just bring in leads.

We did a content gap analysis for each stage of the buyer journey. It showed the company had little content for the middle and bottom of the funnel. Surgeons might find the device through search, but when they compared it to other options, there was nothing to help them decide.

This approach changed marketing from just generating leads to truly supporting sales. Sales reps said the clinical data summaries and ROI calculators made their conversations shorter because procurement teams came to meetings already informed and partly convinced.

What Were the Final Results After 12 Months?

After 12 months, the results beat every expectation. The company had set a cautious first-year revenue target, but a structured go-to-market plan, strong digital presence, targeted messaging, and sales-focused content helped them double their original goals.

The biggest result, besides revenue, was a shorter sales cycle. By giving healthcare professionals and procurement teams the information they needed early, we made the buying process smoother, which is rare in healthcare. This speed let sales reps handle more deals at once, boosting the output of a small sales team.

“Revenue targets exist to keep teams focused, but the real measure of a commercial launch is whether you have built a system that keeps producing results after the initial push. When your digital channels generate leads, your content shortens the sales cycle, and your brand earns trust with buyers, that system compounds month over month.” – Strategy Team, Emulent Marketing.

What Can Other Medical Device Companies Learn From This?

This success did not come from one lucky tactic or a viral moment. It was the result of careful execution across connected marketing and sales activities, all based on a clear understanding of the audience and buying process. Here are the principles we used in this project, which we believe work for most Class II and Class III device launches.

Principles for medical device commercial success:

• Start commercial planning before clearance: The months while a device awaits FDA review are valuable planning time. Build your digital presence, produce content, and prepare your sales materials so you can move quickly once clearance arrives.
• Segment your audience beyond “doctors”: Surgeons, clinical champions, department heads, procurement officers, and hospital administrators all influence the purchase. Each needs messaging that addresses their specific priorities and concerns.
• Invest in digital channels early: SEO and content marketing take time to build momentum. Companies that wait until post-launch to start creating content lose months of compounding organic traffic growth.
• Connect marketing to sales enablement: The best medical device marketing programs do not just generate leads. They provide sales teams with materials that address buyer objections, shorten evaluation periods, and build confidence throughout the committee review process.
• Measure what matters commercially: Impressions and traffic are early indicators, but pipeline contribution, cost per qualified demo, and average sales cycle length are the metrics that connect marketing activity to revenue.

Conclusion

Hitting 200% of first-year revenue targets took the same careful planning as product development and regulatory work. By building a phased go-to-market plan, a strong digital foundation, targeted messaging for each buyer, and content for every sales stage, we helped a small but strong device company become a recognized competitor in just one year.

If your team is preparing to launch a medical device or looking to accelerate revenue for a product already on the market, the Emulent Marketing team can help. We work with pharmaceutical and medical device companies to build commercial strategies that drive measurable growth. Contact the Emulent team today to talk about your medical device marketing goals.